Global Hemoglobin A1C (HbA1C) Testing Strategic Research Report 2023: Market to Reach $2.3 Billion by 2030 from $1.4 Billion in 2022 - Benefits of POC HbA1c Tests Over Lab Tests Drives Adoption - ResearchAndMarkets.com
08 Dec 2023
DUBLIN--(BUSINESS WIRE)--The "Hemoglobin A1C (HbA1C) Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
'Hemoglobin A1C (HbA1C) Testing - Global Strategic Business Report'
Global Hemoglobin A1C (HbA1C) Testing Market to Reach $2.3 Billion by 2030
The global market for Hemoglobin A1C (HbA1C) Testing estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$2.3 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2022-2030. Ion-Exchange High Performance Liquid Chromatography (HPLC), one of the segments analyzed in the report, is projected to record 7.6% CAGR and reach US$915.7 Million by the end of the analysis period. Growth in the Immunoassays segment is estimated at 8.4% CAGR for the next 8-year period.
The report discusses the impact of the COVID-19 pandemic on the utilization of Hemoglobin A1C (HbA1C) laboratory tests, highlighting a new challenge of underutilization. It also provides insights into the competition within the HbA1C testing market, including the global key competitors' percentage market share in 2022.
The importance of HbA1C testing in the monitoring and management of diabetes is emphasized, along with its role in diabetes diagnosis and management. The report includes information on the interpretation of HbA1C levels in NGSP (National Glycohemoglobin Standardization Program) and IFCC (International Federation of Clinical Chemistry and Laboratory Medicine) units as per the American Diabetes AssociationDiabetes Association.
The global market analysis and prospects for HbA1C testing are presented, with a focus on rapid growth in the world HbA1C testing market. While developed regions lead the market, Asia-Pacific is expected to spearhead long-term growth. Chromatography-based Hb testing devices are highlighted as critical tools in the market, with ion-exchange HPLC (High-Performance Liquid Chromatography) tests gaining prominence as reliable diabetes screening tools.
The report also discusses the use of HbA1C testing in point-of-care (POC) settings for diabetes screening and management. It mentions the increasing interest in rapid POC HbA1C testing, which is expected to receive special attention in diabetes screening efforts. Additionally, recent market activity and world brands in the HbA1C testing market are highlighted. The competitive market presence of players worldwide in 2022 is categorized as strong, active, niche, or trivial.
The U.S. Market is Estimated at $397.5 Million, While China is Forecast to Grow at 9.5% CAGR
The Hemoglobin A1C (HbA1C) Testing market in the U.S. is estimated at US$397.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$274.2 Million by the year 2030 trailing a CAGR of 9.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 6.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.
What`s New?
Special discussions on the global economic climate and market sentiment
Coverage on global competitiveness and key competitor percentage market shares
Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and trademarked research platform
Complimentary updates for one year
Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Key Attributes:
Report Attribute
Details
No. of Pages
511
Forecast Period
2022 - 2030
Estimated Market Value (USD) in 2022
$1.4 Billion
Forecasted Market Value (USD) by 2030
$2.3 Billion
Compound Annual Growth Rate
6.4%
Regions Covered
Global
MARKET TRENDS & DRIVERS
World Diabetes and Population Statistics (2019, 2030 & 2045)
World Diabetes Prevalence (2000-2045P)
Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
Diabetes Emerges as One of the Leading Causes of Mortality
Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region: 2019
Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market
Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
Point-of-Care (POC) HbA1c Testing Products/Analyzers of Select Players
Laboratory-based HbA1c Testing Products/Analyzers of Select Players
Major Testing Methods in POC HbA1c Tests
High Risk of Diabetes in Aging Demographics Promises Growth in HbA1c Testing Devices Market
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Increasing Obesity Levels Underpins Market Growth
Average Per Capita Annual Health Expenditure (In US$) due to Obesity
Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
Increasing Healthcare Expenditure Fuels Demand for HbA1c Testing Devices
World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
Variants & Derivatives Affecting Accuracy of HbA1c Testing
Rising Menace of Undiagnosed Diabetes Turns Heads towards Hemoglobin A1c Testing
Number of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Hemoglobin A1C Testing
Technology Developments Transform Diagnostics in Diabetes Care
Non-Invasive Glucose Meters and Continuous Glucose Monitors Offer Viable Alternative to Hemoglobin A1c Monitoring
Role of Hemoglobin A1C Monitoring in Patients with Chronic Kidney Disease
HbA1C Testing Holds Significance as Screening Strategy for Gestational Diabetes
Home HbA1C Testing Market
FOCUS ON SELECT PLAYERS (Total 110 Featured)
A. Menarini Diagnostics Srl
Accruex Biomedical Pvt., Ltd.
American Screening Corporation, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/etlpo2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.